Inspira™ to publish hyla™ clinical results in fourth quarter 2024

The clip-on hyla™ blood sensor, designed to alert physicians of immediate signs of changes in a patient's clinical condition without the need for intermittent actual blood samples, targets a potential $2.5 billion point of care testing and arterial blood gas (abg) analyzer market. ra'anana, israel , aug. 28, 2024  /prnewswire/ -- inspira technologies oxy b.h.n.
IINN Ratings Summary
IINN Quant Ranking